Active ingredientRemimazolamCat. No. P-R032-001CAS 308242-62-8Family · Pharmaceutical analytical standards
Remimazolam
An ultra-short-acting benzodiazepine for sedation during medical procedures and for general anaesthesia, approved in 2020 first in Japan and then in the United States. This family brings together the active ingredient and other impurities.
Did you know?Its molecule carries an ester bond borrowed from the opioid remifentanil: esterase enzymes quickly split it into an inactive metabolite, so patients wake up rapidly.
Go to the active ingredient →Active ingredientRemimazolamCat. No. P-R032-001CAS 308242-62-8
Active ingredientRemimazolam BesylateCat. No. P-R032-002CAS 1001415-66-2
Impurity(R)-Remimazolam BenzenesulfonateCat. No. P-R032-003CAS 1449295-46-8
Impurity2,2-Dimethoxypropan-1-amineCat. No. P-R032-004
Impurity2-Amino-5-bromobenzoic acidCat. No. P-R032-005CAS 5794-88-7
ImpurityN-Boc-D-glutamic Acid 5-Methyl EsterCat. No. P-R032-006CAS 76379-01-6
ImpurityN-Boc-L-glutamic Acid 5-Methyl EsterCat. No. P-R032-007CAS 45214-91-3
ImpurityN-Boc-L-glutamic Acid alpha-Methyl EsterCat. No. P-R032-008CAS 72086-72-7
ImpurityRemimazolam Impurity 1Cat. No. P-R032-009CAS 308242-23-1
ImpurityRemimazolam Impurity 2Cat. No. P-R032-010CAS 1276185-51-3
ImpurityRemimazolam Impurity 3Cat. No. P-R032-011CAS 1275616-57-3
ImpurityRemimazolam Impurity 4Cat. No. P-R032-012CAS 960305-91-3
ImpurityRemimazolam Impurity 5Cat. No. P-R032-013CAS 1860899-55-3
ImpurityRemimazolam Impurity 6Cat. No. P-R032-014CAS 1860899-60-0
ImpurityRemimazolam Impurity 7Cat. No. P-R032-015CAS 2242643-47-4No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.